Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CLDN18.2 overexpression
i
Other names:
CLDN18, Claudin-18, Surfactant, Pulmonary Associated Protein J, Surfactant Associated 5, SFTA5, SFTPJ
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
51208
Related biomarkers:
Expression
Fusion
‹
CLDN18.2 expression (31)
CLDN18.2 positive (15)
CLDN18.2 expression + HER-2 negative (2)
CLDN18.2 positive + HER-2 negative (2)
CLDN18.2 underexpression (2)
HER-2 negative + CLDN18.2 positive (0)
CLDN18.2 expression (31)
CLDN18.2 positive (15)
CLDN18.2 expression + HER-2 negative (2)
CLDN18.2 positive + HER-2 negative (2)
CLDN18.2 underexpression (2)
HER-2 negative + CLDN18.2 positive (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CLDN18.2 overexpression
Gastroesophageal Junction Adenocarcinoma
CLDN18.2 overexpression
Gastroesophageal Junction Adenocarcinoma
zolbetuximab-clzb
Sensitive: C3 – Early Trials
zolbetuximab-clzb
Sensitive
:
C3
zolbetuximab-clzb
Sensitive: C3 – Early Trials
zolbetuximab-clzb
Sensitive
:
C3
CLDN18.2 overexpression
Gastric Cancer
CLDN18.2 overexpression
Gastric Cancer
zolbetuximab-clzb
Sensitive: C3 – Early Trials
zolbetuximab-clzb
Sensitive
:
C3
zolbetuximab-clzb
Sensitive: C3 – Early Trials
zolbetuximab-clzb
Sensitive
:
C3
CLDN18.2 overexpression
Gastric Cancer
CLDN18.2 overexpression
Gastric Cancer
TST001
Sensitive: C3 – Early Trials
TST001
Sensitive
:
C3
TST001
Sensitive: C3 – Early Trials
TST001
Sensitive
:
C3
CLDN18.2 overexpression
Gastroesophageal Junction Adenocarcinoma
CLDN18.2 overexpression
Gastroesophageal Junction Adenocarcinoma
TST001
Sensitive: C3 – Early Trials
TST001
Sensitive
:
C3
TST001
Sensitive: C3 – Early Trials
TST001
Sensitive
:
C3
CLDN18.2 overexpression
Pancreatic Cancer
CLDN18.2 overexpression
Pancreatic Cancer
LM-302
Sensitive: D – Preclinical
LM-302
Sensitive
:
D
LM-302
Sensitive: D – Preclinical
LM-302
Sensitive
:
D
CLDN18.2 overexpression
Gastric Cancer
CLDN18.2 overexpression
Gastric Cancer
LM-302
Sensitive: D – Preclinical
LM-302
Sensitive
:
D
LM-302
Sensitive: D – Preclinical
LM-302
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login